A Pilot Study to Assess Body Mass Composition Measurement Using BIA and Muscle Ultrasound in IPF and PPF Patients on Anti-fibrotic Medications
NCT07332117 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 30
Last updated 2026-01-12
Summary
To assess the impact on body mass composition from anti-fibrotic medications used in fibrotic lung disease by using BIA and muscle ultrasound
Conditions
- Idiopathic Pulmonary Fibrosis (IPF)
- Progressive Pulmonary Fibrosis
Interventions
- OTHER
-
No Interventions
No intervention
- OTHER
-
No intervention
No intervention
Sponsors & Collaborators
-
Royal Brompton & Harefield NHS Foundation Trust
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-09-09
- Primary Completion
- 2026-04-30
- Completion
- 2026-04-30
Countries
- United Kingdom
Study Locations
More Related Trials
-
Exhaled Breath Condensate Biomarkers and Cough in IPF
NCT02630940 ·Status: COMPLETED
-
Inhalation Profiling of Idiopathic Pulmonary Fibrosis (IPF) Patients
NCT02058602 ·Status: COMPLETED ·Phase: PHASE1
-
Feasibility of Proteomics in Chronic Lung Disease With Sarcopenia
NCT06312774 ·Status: NOT_YET_RECRUITING
-
A Study to Characterize the Disease Behavior of Idiopathic Pulmonary Fibrosis (IPF) and Interstitial Lung Disease (ILD) During the Peri-Diagnostic Period
NCT03261037 ·Status: COMPLETED ·Phase: NA
-
Nutritional Status and Intake in Patients With Non-cystic Fibrosis Bronchiectasis (NCFB)
NCT06877091 ·Status: COMPLETED
-
Nutritional Assessment in Idiopathic Pulmonary Fibrosis
NCT03770845 ·Status: COMPLETED
-
Pulmonary Fibrosis Lung Sounds Study
NCT05771740 ·Status: UNKNOWN
-
Study on Phenotypic Characterization of Combined Pulmonary Fibrosis and Emphysema
NCT01121367 ·Status: COMPLETED
-
Study on Disease Progression and Nutritional Status in Bronchiectasis
NCT06344000 ·Status: RECRUITING
-
Protein, Sarcopenic Obesity, and COPD
NCT06735573 ·Status: ENROLLING_BY_INVITATION
-
Determination of Functional Exercise Capacity, Respiratory Muscle Endurance in Idiopathic Pulmonary Fibrosis
NCT06668051 ·Status: NOT_YET_RECRUITING
-
Relationship Between Nutritional State and Respiratory Muscle Weakness in Adult Patients With Bronchietasis
NCT06002334 ·Status: UNKNOWN
-
Fibre Specific Signalling in the Locomotor Myopathy of Chronic Obstructive Pulmonary Disease
NCT01471587 ·Status: UNKNOWN
-
Disease-syndrome Characteristics of IPF
NCT07178392 ·Status: NOT_YET_RECRUITING
-
Respiratory Muscle Strength in Bronchiectasis: Repeatability and Reliability
NCT00487149 ·Status: COMPLETED
-
Role of the Fibroblast Activation Protein (FAP) as Biomarker of Fibrotic Lung Diseases
NCT06189820 ·Status: RECRUITING ·Phase: PHASE2
-
An In Silico Trial to Evaluate Prospectively the Performance of a Radiomics Algorithm for UIP Compared to Medical Doctors
NCT05784207 ·Status: COMPLETED
-
To Evaluate the Use of Radiomics to Classify Between Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease
NCT04430491 ·Status: COMPLETED
-
Investigating Trends in Quality of Life in Patients With Idiopathic Pulmonary Fibrosis (IPF) Under Treatment With Nintedanib
NCT03710824 ·Status: COMPLETED
-
FIBRotic Interstitial Lung Disease and Nocturnal OXygen
NCT04586946 ·Status: COMPLETED
-
Efficacy and Safety of Early Antifibrotic Therapy for Non-progressive Fibrotic Interstitial Lung Disease
NCT07141810 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Nutritional Status in Patients With Acute Exacerbation of Chronic Obstructive Pulmonary Disease
NCT03709498 ·Status: COMPLETED
-
The Role of Quantitative CT and Radiomic Biomarkers for Precision Medicine in Pulmonary Fibrosis
NCT06323876 ·Status: RECRUITING
-
Clinimetric Properties of Outcome Measures in Bronchiectasis in the UK
NCT02468271 ·Status: COMPLETED
-
Assessment of an Exhaled Breath Test to Detect Bronchiectasis
NCT05293314 ·Status: COMPLETED